DUET-UC: A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor
Janssen Research & Development, LLC (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05242484
Collaborator
(none)
550
237
6
25.9
2.3
0.1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or more approved advanced therapy.

Condition or Disease Intervention/Treatment Phase
  • Biological: Guselkumab
  • Biological: Golimumab
  • Biological: JNJ-78934804
  • Drug: Placebo
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
550 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Anticipated Study Start Date :
Jul 22, 2022
Anticipated Primary Completion Date :
Aug 28, 2024
Anticipated Study Completion Date :
Sep 17, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Group 1: Placebo

Participants will receive placebo subcutaneously (SC). All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Drug: Placebo
Placebo will be administered as subcutaneous injection.

Experimental: Group 2: Guselkumab

Participants will receive guselkumab dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Biological: Guselkumab
Guselkumab will be administered as subcutaneous injection.

Experimental: Group 3: Golimumab

Participants will receive golimumab dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Biological: Golimumab
Golimumab will be administered as subcutaneous injection.

Experimental: Group 4: JNJ-78934804 (High-dose)

Participants will receive JNJ-78934804 dose regimen 1 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Biological: JNJ-78934804
JNJ-78934804 will be administered subcutaneously as per defined regimen.

Experimental: Group 5: JNJ-78934804 (Mid-dose)

Participants will receive JNJ-78934804 dose regimen 2 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Biological: JNJ-78934804
JNJ-78934804 will be administered subcutaneously as per defined regimen.

Experimental: Group 6: JNJ-78934804 (Low-dose)

Participants will receive JNJ-78934804 dose regimen 3 SC. All participants who meet inadequate response criteria will be escalated to an active treatment. Participants who are eligible and willing to continue the study intervention that they are receiving at Week 44 may enter the long-term extension.

Biological: JNJ-78934804
JNJ-78934804 will be administered subcutaneously as per defined regimen.

Outcome Measures

Primary Outcome Measures

  1. Percentage of Participants with Clinical Remission at Week 48 [Week 48]

    Percentage of participants with clinical remission at Week 48 will be reported. Clinical remission based on the modified Mayo subscores.

Secondary Outcome Measures

  1. Percentage of Participants with Endoscopic Improvement at Week 48 [Week 48]

    Percentage of participants with endoscopic improvement at Week 48 will be reported. Endoscopic improvement at Week 48 based on the Mayo endoscopic subscore.

  2. Percentage of Participants with Symptomatic Remission at Week 48 [Week 48]

    Percentage of participants with symptomatic remission at Week 48 will be reported. Symptomatic remission at Week 48 based on stool and rectal bleeding symptoms.

  3. Percentage of Participants with Combination of Histological Remission and Endoscopic Improvement at Week 48 [Week 48]

    Percentage of participants with combination of histological remission and endoscopic improvement at Week 48 will be reported. Histologic remission and endoscopic improvement at Week 48 based on the histologic grading and the Mayo endoscopy subscore.

  4. Percentage of Participants with Clinical Remission at Week 24 [Week 24]

    Percentage of participants with clinical remission at Week 24 will be reported. Clinical remission based on the modified Mayo subscores

  5. Percentage of Participants with Adverse Events (AEs) [Up to Week 48]

    An AE is any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product. An AE does not necessarily have a causal relationship with the intervention.

  6. Percentage of Participants with Serious Adverse Events (SAEs) [Up to Week 48]

    A SAE is any untoward medical occurrence that at any dose: results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; is a suspected transmission of any infectious agent via a medicinal product; is medically important.

  7. Serum Concentrations of Guselkumab Over Time [Up to Week 48]

    Serum concentrations of guselkumab over time will be reported. Serum samples will be analyzed to determine concentrations of guselkumab using a validated, specific, and sensitive method.

  8. Serum Concentrations of Golimumab Over Time [Up to Week 48]

    Serum concentration of golimumab over time will be reported. Serum samples will be analyzed to determine concentrations of golimumab using a validated, specific, and sensitive method.

  9. Percentage of Participants with Antibodies to Guselkumab [Up to Week 48]

    Percentage of participants with antibodies to guselkumab will be reported.

  10. Titers of Antibodies to Guselkumab [Up to Week 48]

    Titers of antibodies to guselkumab will be reported.

  11. Percentage of Participants with Antibodies to Golimumab [Up to Week 48]

    Percentage of Participants with Antibodies to golimumab will be reported.

  12. Titers of Antibodies to Golimumab [Up to Week 48]

    Titers of antibodies to golimumab will be reported.

  13. Percentage of Participants with Neutralizing Antibodies to Guselkumab [Up to Week 48]

    Percentage of participants with neutralizing antibodies to guselkumab will be reported.

  14. Percentage of Participants with Neutralizing Antibodies to Golimumab [Up to Week 48]

    Percentage of participants with neutralizing antibodies to golimumab will be reported.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed diagnosis of ulcerative colitis (UC) for at least 3 months prior to baseline

  • Moderately to severely active UC as assessed by the modified Mayo Score

  • Demonstrated inadequate response, loss of response, or intolerance to at least one biologic or novel oral with biologic-like activity

  • If female and of childbearing potential, must meet the contraception and reproduction requirements

Exclusion Criteria:
  • Has severe extensive colitis as defined in the protocol

  • Extent of inflammatory disease limited to the rectum

  • Participants with current diagnosis of indeterminate colitis, microscopic colitis, ischemic colitis, or Crohn's disease (CD)

  • Has a history of, or ongoing, chronic or recurrent infectious disease, including but not limited to, sinopulmonary infections, bronchiectasis, recurrent renal/urinary tract infections (example, pyelonephritis, cystitis), an open, draining, or infected skin wound, or an ulcer

  • Currently has a malignancy or a history of malignancy within 5 years before screening (with the exception of nonmelanoma skin cancer or cervical carcinoma in situ that has been treated with no evidence of recurrence within 12 months of first dose of study intervention)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Valley Gastroenterology Medical Group Arcadia California United States 91006
2 Southern California Research Center Coronado California United States 92118
3 University of California San Diego Health La Jolla California United States 92037
4 Om Research LLC Lancaster California United States 93534
5 Cedars Sinai Medical Center Los Angeles California United States 90048
6 Northshore Gastroenterology Research, LLC San Diego California United States 92103-2120
7 University of Colorado Aurora Colorado United States 80045
8 MedStar Georgetown University Hospital Washington District of Columbia United States 20007
9 Pioneer Research Solutions Inc. Coconut Creek Florida United States 33066
10 Homestead Cardiac & Vein Center Homestead Florida United States 33030
11 Florida Research Center Inc. Lakewood Ranch Florida United States 34211
12 Gastroenterology Group Of Naples Naples Florida United States 34102
13 Omega Research Consultants Orlando Florida United States 32808
14 Central Florida Internists Saint Cloud Florida United States 34769
15 Synergy Clinical Research Saint Petersburg Florida United States 33705
16 Gastroenterolgy Associates of Central GA Macon Georgia United States 31201
17 Gastrointestinal Specialists of Georgia Marietta Georgia United States 30060
18 Gastroenterology Consultants Roswell Georgia United States 30076
19 Grand Teton Gastroenterology Idaho Falls Idaho United States 83404
20 IU Health University Hospital Indianapolis Indiana United States 46202
21 University of Kentucky Chandler Medical Center Lexington Kentucky United States 40536
22 University of Maryland Baltimore Maryland United States 21201
23 Chevy Chase Clinical Research Chevy Chase Maryland United States 20815-7313
24 Huron Gastroenterology Associates Center for Digestive Care Ypsilanti Michigan United States 48197
25 GI Associates Columbia Missouri United States 65201
26 Care Access Las Vegas Las Vegas Nevada United States 89148
27 Crystal Run Healthcare LLP Middletown New York United States 10941
28 Lenox Hill Hospital New York New York United States 10075
29 Mohawk Valley Endoscopy Center Utica New York United States 13502-6313
30 Tryon Medical Group Charlotte North Carolina United States 28210
31 Onsite Clinical Solutions Charlotte North Carolina United States 28277
32 Care Access Research, Kinston Kinston North Carolina United States 28501
33 University Hospitals Case Medical Center Cleveland Ohio United States 44106
34 Cleveland Clinic Cleveland Ohio United States 44195
35 Digestive Specialists, Inc Springboro Ohio United States 45066
36 Care Access Research Scranton Pennsylvania United States 18508
37 Digestive Disease Associates Rock Hill South Carolina United States 29732
38 Etsu Quillen College Of Medicine Johnson City Tennessee United States 37604
39 Vanderbilt University Medical Center Nashville Tennessee United States 37067
40 GI Specialists of Houston Houston Texas United States 77346
41 Gastroenterology Clinic Of San Antonio P A San Antonio Texas United States 78229
42 A1 Clinical Research Spring Texas United States 77386
43 Medical College Of Virginia Hospital Richmond Virginia United States 23249
44 Swedish Medical Center Seattle Washington United States 98104
45 University of Washington Seattle Washington United States 98195
46 Medical College Of Wisconsin Milwaukee Wisconsin United States 53226-3522
47 Hospital de Clínicas José de San Martín Buenos Aires Argentina 1121
48 Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo Ciudad Autonoma Buenos Aires Argentina C1264AAN
49 Hospital Britanico de Buenos Aires Ciudad Autonoma de Buenos Aires Argentina C1280AEB
50 Centro de Investigaciones Medicas Mar Del Plata Mar Del Plata Argentina B7600FYK
51 Box Hill Hospital Box Hill Australia 3128
52 Concord Hospital Concord Australia 2139
53 Western Health Footscray Australia 3011
54 Coastal Digestive Health Maroochydore Australia 4558
55 Royal Perth Hospital Perth Australia 6000
56 The Alfred Hospital Prahran Australia 3004
57 Kepler Universitätsklinikum GmbH Linz Austria 4020
58 Universitätsklinikum Salzburg - Landeskrankenhaus Salzburg Austria 5020
59 Klinikum Wels-Grieskirchen Wels Austria 4600
60 Krankenhaus der Barmherzigen Brüder Wien Austria 1020
61 Medizinische Universität Wien Wien Austria 1090
62 CHU Saint-Pierre Bruxelles Belgium 1000
63 AZ Maria Middelares Gent Belgium 9000
64 CHU de Liège Liege Belgium 4000
65 CHC MontLegia Liège Belgium 4000
66 Vitaz Sint-Niklaas Belgium
67 Fundação Universidade de Caxias do Sul Caxias Do Sul Brazil 95070-560
68 Centro Digestivo de Curitiba - Instituto de Pesquisa Clínica Curitiba Brazil 80430-180
69 Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Goiania Brazil 74535-170
70 Hospital Moinhos de Vento Porto Alegre Brazil 90035-901
71 Hospital de Clínicas de Porto Alegre Porto Alegre Brazil 90035-903
72 UFRJ-Hospital Universitário Clementino Fraga Filho Rio de Janeiro Brazil 21941-913
73 SER - Serviços Especializados em Reumatologia da Bahia Salvador Brazil 40.150-150
74 Praxis pesquisa médica Santo André Brazil 09090-790
75 Irmandade da Santa Casa da Misericórdia de Santos Santos Brazil 11075-101
76 Hospital Do Servidor Publico Estadual Sao Paulo Brazil 04039-901
77 Hospital Nove de Julho São Paulo Brazil 01409-902
78 BR Trials São Paulo Brazil 03325-050
79 Instituto D'Or de Pesquisa e Ensino (IDOR) São Paulo Brazil 04502-001
80 Medical Centre Hipocrat Haskovo Bulgaria 6300
81 Diagnostic Consultative Center - DCC Sv. Pantaleymon EOOD Pleven Bulgaria 5800
82 Diagnostic - Consulting Center I-Sliven Sliven Bulgaria 8800
83 University Hospital Alexandrovska - Clinic of Nephrology Sofia-Grad Bulgaria 1431
84 UMHAT 'Tsaritsa Yoanna' Sofia Bulgaria 1527
85 Medical Center -Medika Plus Veliko Tarnovo Bulgaria 5000
86 Multriprofile Hospital for Active Treatment Hristo Botev Vratsa Bulgaria 3000
87 Columbia Gastroenterology New Westminster British Columbia Canada
88 GIRI Gastrointestinal Research Institute Vancouver British Columbia Canada V6Z 2K5
89 Health Sciences Centre Winnipeg Manitoba Canada R3A 1R9
90 London Health Sciences Centre - University Campus London Ontario Canada N6A 5A5
91 Mount Sinai Hospital Toronto Ontario Canada M5G 1X5
92 St. Jerome Medical Research Saint-Jerome Quebec Canada V8R 4R2
93 Viable Clinical Research Bridgewater Canada B4V 3N2
94 Viable Clinical Research Dartmouth Canada B2W 6L4
95 Hospital Clinico Regional Dr. Guillermo Grant Benavente Concepcion Chile 4030000
96 Clínica Dermacross S.A. Santiago Chile 7640881
97 Complejo Asistencial Hospital Dr. Sótero del Río Santiago Chile 8207257
98 Centro de Estudios Clínicos e Investigación Médica (CeCim) Santiago Chile 8331143
99 Fakultni nemocnice Brno Brno Czechia 625 00
100 Fakultní nemocnice u sv. Anny v Brn Brno Czechia 656 91
101 Klinicke centrum ISCARE Praha 9 Czechia 190 00
102 Aalborg Hospital Aalborg Denmark 9000
103 Bispebjerg Og Frederiksberg Hospital Copenhagen Denmark 2400
104 Herlev Hospital, University of Copenhagen Herlev Denmark 2730
105 Nykøbing F. Sygehus Nykøbing Falster Denmark 4800
106 Odense Universitetshospital Odense Denmark 5000
107 East Tallinn Central Hospital Tallinn Estonia 10138
108 West Tallinn Central Hospital Tallinn Estonia 10617
109 Tartu University Hospital Tartu Estonia 51014
110 CHU Amiens - Hopital Sud AMIENS cedex 1 France 80054
111 Hôpital Beaujon Clichy France 92110
112 Hopital Louis Mourier Colombes Cedex France 92701
113 Centre Hospitalier Universitaire(CHU) - Hopital Henri Mondor Créteil France 94010
114 CHU Grenoble Grenoble France 38700
115 Centre Hospitalier Départemental VENDEE La Roche sur Yon France 85925
116 Hôpital Nord - Marseille Marseille France 13015
117 CHU Nimes - Hôpital Carémeau Nîmes France 30029
118 Hôpital Yves Le Foll Saint-Brieuc France 22027
119 Hopital de Rangueil Toulouse cedex 09 France 31059
120 CHRU Nancy-Brabois Vandoeuvre-les-Nancy France 54511
121 Gastroenterologische Spezialpraxis - Berlin-Karlshorst Berlin-Karlshorst Germany 10318
122 Praxis Für Gastroenteroligie Berlin Germany 10825
123 University Hospital Dresden Dresden Germany 1307
124 Florence Nightingale Krankenhaus Düsseldorf Germany 40489
125 Universitaetsklinik Erlangen Erlangen Germany 91054
126 Agaplesion Frankfurter Diakonie Kliniken GmbH, Markus Krankenhaus Frankfurt/Main Germany 60431
127 Klinikum Fulda - Tumorklinik - Germany Fulda Germany 36043
128 BSF Studiengesellschaft Halle Germany 06108
129 Gastroenterology Outpatient Clinic Prof. Ehehalt/Dr. Hemstäd Heidelberg Germany 69115
130 University Hospital Heidelberg Heidelberg Germany 69120
131 Universitätsklinikum Jena Jena Germany 07747
132 Eugastro GmbH Leipzig Germany 04103
133 Gemeinschaftspraxis Mainz Mitte am Gesundheitscentrum Mainz Mainz Germany 55116
134 Universitatsklinikum Mannheim Mannheim Germany 68167
135 Klinikum der Universität München Munich Germany 81377
136 Praxis fur Innere Medizin und Gastroenterologie Munster Germany 48149
137 MVZ Portal 10 Münster Germany 48155
138 Medius Klinik Nürtingen Nürtingen Germany 72622
139 Zentrum für Gastroenterologie Saar MVZ GmbH Saarbrücken Germany 66111
140 Universitätsklinikum Ulm Ulm Germany 89070
141 Gemeinschaftspraxis Jakobeit Wipperfürth Germany 51688
142 Universitätsklinikum Würzburg Würzburg Germany 97080
143 General Hospital of Athens 'G. Gennimatas' Athens Greece 115 27
144 Sotiria General State Hospital of Chest Diseases Athens Greece 115 27
145 Alexandra General Hospital of Athens Athens Greece 11528
146 Nikaia General Hospital Piraievs Greece 184 54
147 Hippokration Hospital Thessaloniki Greece 54642
148 Obudai Egeszsegugyi Centrum Kft. Budapest Hungary 1036
149 Pannónia Magánorvosi Centrum Kft Budapest Hungary H-1136
150 Szegedi Tud.Egyetem Szent-Gyorgyi Albert Klin. Közp. Szeged Hungary 6720
151 M S Ramaiah Medical College and Hospital Bangalore India 560054
152 Apex Hospitals Ltd Jaipur India 302017
153 All India Institute of Medical Sciences New Delhi India 110029
154 Sir Ganga Ram Hospital New Delhi India 110060
155 Yashoda Super Speciality Hospitals Secunderabad India 500003
156 Haemek Medical Center - Afula Afula Israel 1834111
157 Shaare Zedek Medical Center Jerusalem Israel 9103102
158 Tel Aviv Sourasky Medical Center Tel Aviv Israel 6423906
159 The Chaim Sheba Medical Center Tel Hashomer Israel 52621
160 A.O. Per L' Emergenza Cannizzaro - U.O. Chirurgia Generale Catania Italy 95126
161 AOU Policlinico G.Martino Messina Italy 98125
162 Ospedale San Raffaele HSR Istituto Scientifico Universitario San Raffaele Milano Italy 20132
163 Azienda Ospedaliero Universitaria di Cagliari - Policlinico Duilio Casula di Monserrato Monserrato Italy 09042
164 Universita degli Studi di Padova - Azienda Ospedaliera di Padova Padova Italy 35128
165 Policlinico Universitario Agostino Gemelli Roma Italy 00168
166 Casa Sollievo della Sofferenza San Giovanni Rotondo Italy 71013
167 Ospedale Molinette, AO Città della Salute e della Scienza di Torino Italy 10126
168 Kosin University Gospel Hospital Busan Korea, Republic of 49267
169 Kyungpook National University Hospital Daegu Korea, Republic of 41944
170 Chungnam National University Hospital Daejeon Korea, Republic of 35015
171 Hallym University Dongtan Sacred Heart Hospital Hwaseong-si Korea, Republic of 18450
172 Kangbuk Samsung Hospital Seoul Korea, Republic of 03181
173 Severance Hospital, Yonsei University Health System Seoul Korea, Republic of 03722
174 The Catholic University of Korea, Seoul St.Mary's Hospital Seoul Korea, Republic of 06591
175 The Catholic University of Korea, Seoul St.Mary's Hospital Seoul Korea, Republic of 6591
176 Lietuvos sveikatos mokslų universiteto ligoninė Kauno klinik Kaunas Lithuania LT-50009
177 Clinica de Investigacion en Reumatologia y Obesidad Guadalajara Mexico 44650
178 Centro Regiomontano de Estudios Clínicos Roma S.C. Monterrey Mexico 64610
179 Hospital Universitatio de Saltillo Saltillo Mexico 25020
180 Academisch Medisch Centrum Universiteit van Amsterdam Amsterdam Netherlands 105 AZ
181 Albert Schweitzer Ziekenhuis Dordrecht Netherlands 3318 AT
182 Leiden University Medical Center Leiden Netherlands 2333 ZA
183 Erasmus Medisch Centrum Rotterdam Netherlands 3015 GD
184 Ikazia Ziekenhuis Rotterdam Netherlands 3083 AN
185 UMC Utrecht Utrecht Netherlands 3584 CX
186 Hutt Hospital Lower Hutt New Zealand 5010
187 Sykehuset Immlandet HF Gjøvik Gjøvik Norway 2819
188 Akershus Universitetssykehus Lørenskog Norway 1478
189 Lovisenberg Diakonale Sykehus Oslo Norway 0440
190 Oslo University Hospital HF Ullevål sykehus Oslo Norway 0450
191 St. Olavs Hospital Trondheim Norway 7030
192 Centrum Opieki Zdrowotnej Orkan-med Stec-Michalska sj Ksawerów Poland 95-054
193 AmiCare Centrum Medyczne Lodz Poland 90-644
194 Pracownia Endoskopowa Szpital Zakonu Bonifratrow sw. Jana Bozego w Lodzi sp. z o.o. Lodz Poland 93-357
195 ETG Lublin Lublin Poland 20-412
196 Wojewodzki Szpital Specjalistyczny w Olsztynie Olsztyn Poland 10-561
197 EuroMediCare Szpital Specjalistyczny z Przychodnia Wroclaw Poland 54-144
198 Centro Hospitalar de Lisboa Norte - Hospital Santa Maria Lisboa Portugal 1649-035
199 Hospital Beatriz Angelo Loures Portugal 2674-514
200 Military Medical Academy, Clinic for Psychiatry Belgrade Serbia 11000
201 University Clinical Center of Serbia Belgrade Serbia 11000
202 University Clinical Hospital Center Dr Dragisa Misovic- Dedi Belgrade Serbia 11000
203 Zvezdara University Medical Center Belgrade Serbia 11000
204 General Hospital Vrsac Vrsac Serbia 26300
205 General Hospital 'Djordje Joanovic' Zrenjanin Serbia 23000
206 FNsP F.D.R. Banska Bystrica Banska Bystrica Slovakia 974 01
207 GASTRO I. s.r.o. Presov Slovakia 080 01
208 Gastroenterology Department ENDOMED, s.r.o. Vranov nad Toplou Slovakia 093 01
209 Splosna bolnisnica Celje Celje Slovenia 3000
210 Univerzitetni klinicni center Ljubljana Ljubljana Slovenia 1000
211 UKS Maribor Maribor Slovenia 2000
212 Hosp. Clinic I Provincial de Barcelona Barcelona Spain 08036
213 Hosp. Univ. La Paz Madrid Spain 28046
214 Hosp. de Navarra Pamplona Spain 31008
215 Corporacio Sanitari Parc Tauli Sabadell Spain 8208
216 Hosp. Univ. Marques de Valdecilla Santander Spain 39008
217 Hosp. Univ. de Torrejon Torrejón de Ardoz Spain 28850
218 Hosp. Clinico Univ. de Valencia Valencia Spain 46010
219 Hosp. Alvaro Cunqueiro Vigo Spain 36213
220 INSELSPITAL, Universitätsspital Bern Bern Switzerland 3010
221 Gastroenterologische Praxis Balsiger und Seibold Bern Switzerland 3012
222 Spital Bülach Bülach Switzerland 8180
223 Hôpitaux Universitaires de Genève - HUG Genève Switzerland 1205
224 UniversitaetsSpital Zuerich Zuerich Switzerland 8091
225 Changhua Christian Hospital Changhua Taiwan 500
226 National Cheng Kung University Hospital Tainan Taiwan 70403
227 National Taiwan University Hospital, Division of Infectious Diseases Taipei Taiwan 100
228 Acibadem Fulya Hospital D:14/4 Nisantasi Turkey 34340
229 Ege Universitesi Tip Fakultesi Izmir Turkey 35100
230 Mersin University Medical Faculty Mersin Turkey 33343
231 Karadeniz Teknik University Medical Faculty Trabzon Turkey 61080
232 North Tyneside General Hospital Hexham United Kingdom NE46 1QJ
233 Egin Research High Wycombe United Kingdom HP112QW
234 Airedale General Hospital Keighley United Kingdom BD20 6TD
235 Whipps Cross University Hospital London United Kingdom E11 1NR
236 Guy's and St Thomas' Hospital London United Kingdom SE1 7EH
237 St George's University Hosptial NHS Foundation Trust London United Kingdom SW17 0QT

Sponsors and Collaborators

  • Janssen Research & Development, LLC

Investigators

  • Study Director: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Janssen Research & Development, LLC
ClinicalTrials.gov Identifier:
NCT05242484
Other Study ID Numbers:
  • CR109179
  • 78934804UCO2001
  • 2021-005528-39
First Posted:
Feb 16, 2022
Last Update Posted:
Jul 15, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2022